Early Pathogenesis of Cystic Fibrosis Related Diabetes

囊性纤维化相关糖尿病的早期发病机制

基本信息

  • 批准号:
    10599931
  • 负责人:
  • 金额:
    $ 147.99万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2021
  • 资助国家:
    美国
  • 起止时间:
    2021-04-30 至 2024-03-31
  • 项目状态:
    已结题

项目摘要

1 Project Summary 2 Cystic Fibrosis (CF) is the most common lethal autosomal recessive disorder in Caucasian populations and is 3 caused by defects in the cystic fibrosis conductance regulator (CFTR) chloride channel. CF is a multi-organ 4 disease affecting the lung, pancreas, liver, intestine, and gallbladder. Cystic fibrosis related diabetes (CFRD) is 5 the most common severe complication of CF and is associated with increased morbidity and mortality. CFRD, 6 which is pathophysiologically distinct from type 1 and type 2 diabetes, significantly worsens the nutritional and 7 pulmonary health of CF patients. Our studies in CF ferrets and children 3 months to 6 years of age suggest that 8 the underpinnings of CFRD occur very early in life when acinar cells are lost and inflammatory/fibrotic remodeling 9 occurs. In CF ferrets, this exocrine-driven pancreatic remodeling leads to a glycemic crisis caused by b-cell loss 10 and/or dysfunction. Interestingly, the emergence of newly formed b-cells in CF ferrets coincides with a transient 11 recovery in glycemic control. Nonetheless, those CF ferrets with the greatest early-life glycemic disturbances go 12 on to develop CFRD later in life. We have also reported that a similar pattern of glycemic disturbance and 13 recovery occurs in young CF children. Our central hypothesis proposes that new b-cells in the CF ferret pancreas 14 are derived from exocrine progenitors and/or committed dedifferentiated b-cells. Three lineage tracing ferret 15 models will be used to fate map b-cell progenitors (INS-IRES-CreERT2), ductal-derived endocrine progenitors 16 (KRT7-IRES-CreERT2), and acinar-derived endocrine progenitors (PTF1A-IRES-CreERT2). The use of an additional 17 CFTRG551D ferret model, which affords temporal control of pancreatic disease onset using the CFTR modulator 18 VX-770, will allow for dissection of how the developmental timing of pancreatitis impact progenitor cell states 19 and longer-term progression of CFRD. Our in vivo and in vitro preliminary data also show that CF ferret ductal 20 cells acquire properties consistent with the transcriptional and epigenetic states found in pancreatic progenitors 21 during development. The mechanisms of this alteration will be investigated by using in vitro models and the study 22 of pancreatic progenitor cell specification during in utero development of the CF ferret pancreas. The proposed 23 research has brought together two institutions with expertise in animal modeling of CF pancreatic disease, 24 lineage-tracing of islet endocrine precursors, and integrated physiology of CFRD to delineate the mechanism of 25 islet resurgence in CF using the first ever non-rodent lineage-tracing models. These studies are expected to 26 identify mechanisms not only relevant to CFRD, but also other forms of pancreatogenic diabetes.
1项目概述

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

JOHN F ENGELHARDT其他文献

JOHN F ENGELHARDT的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('JOHN F ENGELHARDT', 18)}}的其他基金

Biology of Submucosal Gland Stem Cells in the Airway
气道粘膜下腺干细胞的生物学
  • 批准号:
    10516449
  • 财政年份:
    2022
  • 资助金额:
    $ 147.99万
  • 项目类别:
National Ferret Research and Resource Institute (NFRRI) at University of Iowa
爱荷华大学国家雪貂研究与资源研究所 (NFRRI)
  • 批准号:
    10596901
  • 财政年份:
    2022
  • 资助金额:
    $ 147.99万
  • 项目类别:
Biology of Submucosal Gland Stem Cells in the Airway
气道粘膜下腺干细胞的生物学
  • 批准号:
    10649543
  • 财政年份:
    2022
  • 资助金额:
    $ 147.99万
  • 项目类别:
Early Pathogenesis of Cystic Fibrosis Related Diabetes
囊性纤维化相关糖尿病的早期发病机制
  • 批准号:
    10397094
  • 财政年份:
    2021
  • 资助金额:
    $ 147.99万
  • 项目类别:
Conducting Airway Cellular Targets Required for Complementation of CF Lung Disease
传导补充 CF 肺病所需的气道细胞靶点
  • 批准号:
    10470338
  • 财政年份:
    2020
  • 资助金额:
    $ 147.99万
  • 项目类别:
Conducting Airway Cellular Targets Required for Complementation of CF Lung Disease
传导补充 CF 肺病所需的气道细胞靶点
  • 批准号:
    10677622
  • 财政年份:
    2020
  • 资助金额:
    $ 147.99万
  • 项目类别:
Conducting Airway Cellular Targets Required for Complementation of CF Lung Disease
传导补充 CF 肺病所需的气道细胞靶点
  • 批准号:
    10248531
  • 财政年份:
    2020
  • 资助金额:
    $ 147.99万
  • 项目类别:
Conducting Airway Cellular Targets Required for Complementation of CF Lung Disease
传导补充 CF 肺病所需的气道细胞靶点
  • 批准号:
    10024668
  • 财政年份:
    2020
  • 资助金额:
    $ 147.99万
  • 项目类别:
National Ferret Resource and Research Center on Lung Disease
国家雪貂资源与肺部疾病研究中心
  • 批准号:
    8751112
  • 财政年份:
    2014
  • 资助金额:
    $ 147.99万
  • 项目类别:
National Ferret Resource and Research Center on Lung Disease
国家雪貂资源与肺部疾病研究中心
  • 批准号:
    9283593
  • 财政年份:
    2014
  • 资助金额:
    $ 147.99万
  • 项目类别:

相似国自然基金

基于ATAC-seq与DNA甲基化测序探究染色质可及性对莲两生态型地下茎适应性分化的作用机制
  • 批准号:
  • 批准年份:
    2024
  • 资助金额:
    0.0 万元
  • 项目类别:
    省市级项目
利用ATAC-seq联合RNA-seq分析TOP2A介导的HCC肿瘤细胞迁移侵 袭的机制研究
  • 批准号:
  • 批准年份:
    2024
  • 资助金额:
    0.0 万元
  • 项目类别:
    省市级项目
面向图神经网络ATAC-seq模体识别的最小间隔单细胞聚类研究
  • 批准号:
    62302218
  • 批准年份:
    2023
  • 资助金额:
    30.00 万元
  • 项目类别:
    青年科学基金项目
基于ATAC-seq策略挖掘穿心莲基因组中调控穿心莲内酯合成的增强子
  • 批准号:
  • 批准年份:
    2022
  • 资助金额:
    33 万元
  • 项目类别:
    地区科学基金项目
基于单细胞ATAC-seq技术的C4光合调控分子机制研究
  • 批准号:
  • 批准年份:
    2021
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
基于ATAC-seq技术研究交叉反应物质197调控TFEB介导的自噬抑制子宫内膜异位症侵袭的分子机制
  • 批准号:
    82001520
  • 批准年份:
    2020
  • 资助金额:
    24.0 万元
  • 项目类别:
    青年科学基金项目
靶向治疗动态调控肺癌细胞DNA可接近性的ATAC-seq分析
  • 批准号:
    81802809
  • 批准年份:
    2018
  • 资助金额:
    21.0 万元
  • 项目类别:
    青年科学基金项目
运用ATAC-seq技术分析染色质可接近性对犏牛初级精母细胞基因表达的调控作用
  • 批准号:
    31802046
  • 批准年份:
    2018
  • 资助金额:
    27.0 万元
  • 项目类别:
    青年科学基金项目
基于ATAC-seq和RNA-seq研究CWIN调控采后番茄果实耐冷性作用机制
  • 批准号:
    31801915
  • 批准年份:
    2018
  • 资助金额:
    24.0 万元
  • 项目类别:
    青年科学基金项目
基于ATAC-seq高精度预测染色质相互作用的新方法和基于增强现实的3D基因组数据可视化
  • 批准号:
    31871331
  • 批准年份:
    2018
  • 资助金额:
    59.0 万元
  • 项目类别:
    面上项目

相似海外基金

Project #2 Integrated single-nucleus multi-omics (ATAC-seq+RNA-seq or chromatin accessibility + RNA-seq) of human TGs
项目
  • 批准号:
    10806548
  • 财政年份:
    2023
  • 资助金额:
    $ 147.99万
  • 项目类别:
A transposase system for integrative ChIP-exo and ATAC-seq analysis at single-cell resolution
用于单细胞分辨率综合 ChIP-exo 和 ATAC-seq 分析的转座酶系统
  • 批准号:
    10210424
  • 财政年份:
    2018
  • 资助金额:
    $ 147.99万
  • 项目类别:
EAPSI: Developing Single Nucleus ATAC-seq to Map the Ageing Epigenome
EAPSI:开发单核 ATAC-seq 来绘制衰老表观基因组图谱
  • 批准号:
    1714070
  • 财政年份:
    2017
  • 资助金额:
    $ 147.99万
  • 项目类别:
    Fellowship Award
A cloud-based learning module to analyze ATAC-seq and single cell ATAC-seq data
基于云的学习模块,用于分析 ATAC-seq 和单细胞 ATAC-seq 数据
  • 批准号:
    10558379
  • 财政年份:
    2001
  • 资助金额:
    $ 147.99万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了